Dr. Hanifin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 503-418-3376Fax+1 503-494-6907
Education & Training
University of California (San Francisco)Residency, Dermatology, 1967 - 1969
Zuckerberg San Francisco General Hospital and Trauma CenterInternship, Transitional Year, 1965 - 1966
University of Wisconsin School of Medicine & Public HealthClass of 1965
Certifications & Licensure
OR State Medical License 1972 - 2025- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2005-2014
- Portland Monthly Magazine Castle Connolly, 2011
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Join now to see all
Clinical Trials
- Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis Start of enrollment: 2008 Aug 01
- An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis Start of enrollment: 2006 Nov 01
- Group Eczema Education Visits:Impact on Patient and Family Quality of Life Start of enrollment: 2010 May 01
- Join now to see all
Publications & Presentations
PubMed
- 22 citationsAir Pollution and Atopic Dermatitis, from Molecular Mechanisms to Population-Level Evidence: A Review.Raj P Fadadu, Katrina Abuabara, John R Balmes, Jon M Hanifin, Maria L Wei
International Journal of Environmental Research and Public Health. 2023-01-31 - 186 citationsWhat the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study.Yael Anne Leshem, Tamar Hajar, Jon M. Hanifin, Eric L. Simpson
The British Journal of Dermatology. 2015-05-01 - 4 citationsDupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical ...Jonathan I Silverberg, Mark Boguniewicz, Jon Hanifin, Kim A Papp, Haixin Zhang
Dermatology and Therapy. 2022-12-01
Press Mentions
Reviewers' List December 2019August 23rd, 2019
Dupixent Likely to Maintain Its Position in the Market for Atopic DermatitisApril 9th, 2019
First Childhood Eczema, Then Adult-Onset Atopic DermatitisNovember 7th, 2017- Join now to see all
Grant Support
- International Symposium On Atopic DermatitisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2001
- Double Blind, Placebo Controlled Study Of Ctla4ig In Patients With PsoriasisNational Center For Research Resources1998–1999
- Monocyte Control Of IL 4 Expression In Atopic DermatitisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1995–1997
- Pharmacokinetics, Safety And Efficacy Using Dup 785 In PsoriasisNational Center For Research Resources1992–1993
- Phosphodiesterase Studies In Atopic DermatitisNational Institute Of Allergy And Infectious Diseases1985–1990
- Receptor Pharmacology In Atopic DermatitisNational Institute Of Allergy And Infectious Diseases1985–1987
Professional Memberships
- Fellow
External Links
- OHSU Dermatologyhttp://www.ohsu.edu/xd/health/services/providers/hanifinj.cfm?fromsearch=1
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
